Valuation: Kintor Pharmaceutical Limited

Market Cap 880M 1.02B 130M 113M 104M 97.12M 184M 12.35B 187M 1.25B 486M 6.07B 487M 476M 20.92B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 934M 1.08B 138M 120M 111M 103M 195M 13.1B 198M 1.33B 516M 6.44B 517M 506M 22.2B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
83.05%
Yield 2024 *
-
Yield 2025 -
1 day+3.52%
1 week+11.35%
Current month+7.85%
1 month-22.56%
3 months-21.97%
6 months+0.98%
Current year+5.10%
1 week 1.85
Extreme 1.85
2.1
1 month 1.82
Extreme 1.82
2.6
Current year 1.82
Extreme 1.82
4.7
1 year 1.5
Extreme 1.5
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
89
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 24/03/2009
Director of Finance/CFO 49 14/04/2023
Chief Tech/Sci/R&D Officer 49 01/09/2020
Director TitleAgeSince
Director/Board Member 62 12/08/2019
Director/Board Member 61 12/08/2019
Chairman 64 24/03/2009
Date Insider Type Main position Quantity % Market Cap.
06-25Other

Chief Executive Officer

250,000 0.0501%
06-09Other

Chief Executive Officer

75,000 0.0150%
05-21Other

Chief Executive Officer

38,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
+3.52%+11.35%+41.10%-44.62% 130M
+0.68%+5.92%+80.45%+137.78% 59.1B
+2.32%+5.03%+75.51%+94.88% 55.19B
+3.86%+6.93%-11.32%-9.53% 24.67B
+4.30%+7.95%+14.11%+437.83% 24.19B
+4.74%+13.68%+45.58%-1.42% 19.69B
-0.29%+9.78%+44.62%-27.94% 17.56B
0.00%+20.78%+178.93%+360.74% 16.22B
+3.50%+1.97%+21.02%+191.95% 14.04B
+6.72%+19.38%+42.82% - 14.84B
Average +2.94%+8.84%+53.28%+126.63% 24.56B
Weighted average by Cap. +2.46%+6.48%+59.05%+137.61%

Financials

2024 2025
Net sales 5 5.78 0.74 0.64 0.59 0.55 1.05 70.14 1.06 7.1 2.76 34.48 2.77 2.71 118.8 32.68 37.76 4.81 4.21 3.87 3.61 6.84 458.45 6.94 46.44 18.05 225.35 18.07 17.69 776.54
Net income -155M -179M -22.88M -20M -18.38M -17.13M -32.5M -2.18B -32.99M -221M -85.78M -1.07B -85.88M -84.03M -3.69B -200M -231M -29.48M -25.77M -23.68M -22.08M -41.87M -2.81B -42.51M -284M -111M -1.38B -111M -108M -4.75B
Net Debt -15.68M -18.12M -2.31M -2.02M -1.86M -1.73M -3.28M -220M -3.33M -22.28M -8.66M -108M -8.67M -8.48M -373M 53.86M 62.24M 7.94M 6.94M 6.37M 5.94M 11.27M 756M 11.44M 76.53M 29.75M 371M 29.79M 29.15M 1.28B
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
123
Date Price Change Volume
03/07/26 HK$2.060 +3.52% 1,227,500
02/07/26 HK$1.990 +4.19% 510,500
30/06/26 HK$1.910 -4.50% 286,500
29/06/26 HK$2.000 +8.11% 839,500
26/06/26 HK$1.850 -8.42% 2,235,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock